Katherine L B Borden (Katherine Lb Borden, Klb Borden)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 12

Top Topics

Transcription Factor

Top Venues

Nucleus (Austin, Tex.)

BioEssays : news and reviews in molecular, cellular and developmental biology

The EMBO journal

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Jean-Clement Mars, Biljana Culijkovic, Katherine L B Borden
eIF4E orchestrates mRNA processing, RNA export and translation to modify specific protein production. Nucleus (Austin, Tex.) 15 (1) (2024)
Jean-Clement Mars, Biljana Culijkovic, Katherine L B Borden
eIF4E orchestrates mRNA processing, RNA export and translation to modify specific protein production. Nucleus (Austin, Tex.) 15 (1) (2024)
Jean-Clement Mars, Biljana Culijkovic, Katherine L B Borden
eIF4E orchestrates mRNA processing, RNA export and translation to modify specific protein production. Nucleus (Austin, Tex.) 15 (1) (2024)
Rossella Marullo, Sarah C Rutherford, Maria Victoria Revuelta, Nahuel Zamponi, Biljana Culijkovic, Nikita Kotlov, Nicolás Di Siervi, Juan Lara-Garcia, John N Allan, Jia Ruan, Richard R Furman, Zhengming Chen, Tsiporah B Shore, Adrienne A Phillips, Sebastian Mayer, Jingmei Hsu, Koen van Besien, John P Leonard, Katherine L B Borden, Giorgio Ga Inghirami, Peter Martin, Leandro Cerchietti
XPO1 enables adaptive regulation of mRNA export required for genotoxic stress tolerance in cancer cells. Cancer research (2023)
Katherine L B Borden
The eukaryotic translation initiation factor eIF4E unexpectedly acts in splicing thereby coupling mRNA processing with translation: eIF4E induces widescale splicing reprogramming providing system-wide connectivity between splicing, nuclear mRNA export and translation. BioEssays : news and reviews in molecular, cellular and developmental biology (2023)
Mehdi Ghram, Gavin Morris, Biljana Culijkovic, Jean-Clement Mars, Patrick Gendron, Lucy Skrabanek, Maria Victoria Revuelta, Leandro Cerchietti, Monica L Guzman, Katherine L B Borden
The eukaryotic translation initiation factor eIF4E reprograms alternative splicing. The EMBO journal (2023)
Katherine L B Borden
Cancer cells hijack RNA processing to rewrite the message. Biochemical Society transactions 50 (5) (2022)
Katherine L B Borden
The search for genetic dark matter and lessons learned from the journey. Biochemistry and cell biology = Biochimie et biologie cellulaire 100 (4) (2022)
Katherine L B Borden, B Culjkovic-Kraljacic, V H Cowling
To cap it all off, again: dynamic capping and recapping of coding and non-coding RNAs to control transcript fate and biological activity. Cell cycle (Georgetown, Tex.) 20 (14) (2021)
Katherine L B Borden, Laurent Volpon
The diversity, plasticity, and adaptability of cap-dependent translation initiation and the associated machinery. RNA biology 17 (9) (2020)
Hiba Ahmad Zahreddine, Biljana Culjkovic-Kraljacic, Jadwiga Gasiorek, Jean Duchaine, Katherine L B Borden
GLI1-Inducible Glucuronidation Targets a Broad Spectrum of Drugs. ACS chemical biology 14 (3) (2019)
Hiba Ahmad Zahreddine, Biljana Culjkovic-Kraljacic, Audrey Emond, Filippa Pettersson, Ronald Midura, Mark Lauer, Sonia Del Rincon, Valbona Cali, Sarit Assouline, Wilson H Miller, Vincent Hascall, Katherine L B Borden
The eukaryotic translation initiation factor eIF4E harnesses hyaluronan production to drive its malignant activity. eLife 6 (2017)